We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Read MoreHide Full Article
Cardinal Health (CAH - Free Report) closed at $133.69 in the latest trading session, marking a +1.92% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 2.51%. Elsewhere, the Dow gained 2.66%, while the tech-heavy Nasdaq added 2.71%.
The prescription drug distributor's shares have seen a decrease of 1.53% over the last month, surpassing the Medical sector's loss of 11.09% and the S&P 500's loss of 8.86%.
The upcoming earnings release of Cardinal Health will be of great interest to investors. The company's earnings report is expected on May 1, 2025. The company's upcoming EPS is projected at $2.15, signifying a 3.37% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $55.03 billion, up 0.21% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $7.94 per share and a revenue of $222.62 billion, signifying shifts of +5.44% and -1.92%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Cardinal Health. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.05% lower. Cardinal Health currently has a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Cardinal Health has a Forward P/E ratio of 16.52 right now. This signifies a discount in comparison to the average Forward P/E of 17.38 for its industry.
It's also important to note that CAH currently trades at a PEG ratio of 1.73. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Dental Supplies industry had an average PEG ratio of 1.68 as trading concluded yesterday.
The Medical - Dental Supplies industry is part of the Medical sector. With its current Zacks Industry Rank of 89, this industry ranks in the top 36% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Cardinal Health (CAH - Free Report) closed at $133.69 in the latest trading session, marking a +1.92% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 2.51%. Elsewhere, the Dow gained 2.66%, while the tech-heavy Nasdaq added 2.71%.
The prescription drug distributor's shares have seen a decrease of 1.53% over the last month, surpassing the Medical sector's loss of 11.09% and the S&P 500's loss of 8.86%.
The upcoming earnings release of Cardinal Health will be of great interest to investors. The company's earnings report is expected on May 1, 2025. The company's upcoming EPS is projected at $2.15, signifying a 3.37% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $55.03 billion, up 0.21% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $7.94 per share and a revenue of $222.62 billion, signifying shifts of +5.44% and -1.92%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Cardinal Health. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.05% lower. Cardinal Health currently has a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Cardinal Health has a Forward P/E ratio of 16.52 right now. This signifies a discount in comparison to the average Forward P/E of 17.38 for its industry.
It's also important to note that CAH currently trades at a PEG ratio of 1.73. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Dental Supplies industry had an average PEG ratio of 1.68 as trading concluded yesterday.
The Medical - Dental Supplies industry is part of the Medical sector. With its current Zacks Industry Rank of 89, this industry ranks in the top 36% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.